DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Fisicaro P, Valdatta C, Massari M. , et al.
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Gastroenterology 2012;
143 (06) 1576-1585.e4
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.